Osteoarthritis in People with Multiple Sclerosis: A Systematic Review and Meta-Analysis

被引:0
|
作者
Giannopapas, Vasileios [1 ,2 ]
Smyrni, Vassiliki [1 ]
Kitsos, Dimitrios K. [1 ]
Stasi, Sophia [3 ]
Chasiotis, Athanasios K. [1 ,2 ]
Moschovos, Christos [1 ]
Papagiannopoulou, Georgia [1 ]
Stavrogianni, Konstantina [1 ,4 ]
Kosmidou, Maria [5 ]
Bakalidou, Daphne [1 ]
Tzartos, John S. [1 ]
Tsivgoulis, Georgios [1 ]
Giannopoulos, Sotirios [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Dept Neurol 2, Athens 11528, Greece
[2] Univ West Attica, Dept Phys Therapy, Egaleo 12243, Greece
[3] Univ Peloponnese, Dept Phys Therapy, Sparti 23100, Greece
[4] Univ Ioannina, Fac Med, Dept Physiol, 45110 Ioannina, Greece
[5] Univ Ioannina, Fac Med, Dept Internal Med, Ioannina 45110, Greece
关键词
multiple sclerosis; arthritis; osteoarthritis; autoimmune diseases; NATIONAL BURDEN; GLOBAL BURDEN; DISEASE; EPIDEMIOLOGY; STROKE;
D O I
10.3390/jcm13175015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Arthritis, particularly osteoarthritis (OA), is a common synovial condition observed in individuals with multiple sclerosis (MS). Despite its high prevalence and significant impact on the quality of life of MS individuals, there is a gap in the current literature regarding the prevalence of OA in this population and its relation to MS pathology. This systematic review and meta-analysis aimed to estimate the prevalence of OA in the MS population and explore potential associations with demographic and MS-specific characteristics. Methods: Adhering to PRISMA guidelines, a systematic search of the MEDLINE PubMed, Scopus and Google Scholar databases was conducted. Results: Fifteen studies were included in the systematic review and meta-analysis. The aggregated prevalence of OA in the MS population was 27% (95% CI: 15-40%), with substantial heterogeneity (I2 = 99.9%). Sensitivity analysis, excluding one study, showed a prevalence of 21% (95% CI: 16-28%). The risk ratio of OA in MS versus controls was 1.07 (95% CI: 0.84-1.37), indicating no significant difference. Meta-regression revealed no associations between OA prevalence and age or disease duration in MS patients. Conclusions: This study reports a 21-27% prevalence of OA in people with MS. Understanding the implications of OA in pain and mobility domains, as well as the challenges in distinguishing OA symptoms from MS manifestations, underscores the need for further research to elucidate the pathophysiological mechanisms and interactions between these conditions. Additional studies are warranted to enhance clinical management and improve outcomes for individuals with MS and co-existing OA.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Cognitive performance and magnetic resonance imaging in people with multiple sclerosis: A systematic review and meta-analysis
    Mirmosayyeb, Omid
    Nabizadeh, Fardin
    Ghaffary, Elham Moases
    Panah, Mohammad Yazdan
    Zivadinov, Robert
    Weinstock-Guttman, Bianca
    Benedict, Ralph H. B.
    Jakimovski, Dejan
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 88
  • [42] Telephone Psychotherapy in Multiple Sclerosis: A Systematic Review and Meta-Analysis
    Proctor, Barnaby J.
    Moghaddam, Nima
    Vogt, William
    das Nair, Roshan
    REHABILITATION PSYCHOLOGY, 2018, 63 (01) : 16 - 28
  • [43] Statin Treatment in Multiple Sclerosis: A Systematic Review and Meta-Analysis
    Pihl-Jensen, Gorm
    Tsakiri, Anna
    Frederiksen, Jette Lautrup
    CNS DRUGS, 2015, 29 (04) : 277 - 291
  • [44] Social cognition in multiple sclerosis A systematic review and meta-analysis
    Cotter, Jack
    Firth, Joseph
    Enzinger, Christian
    Kontopantelis, Evangelos
    Yung, Alison R.
    Elliott, Rebecca
    Drake, Richard J.
    NEUROLOGY, 2016, 87 (16) : 1727 - 1736
  • [45] The indirect costs of multiple sclerosis: systematic review and meta-analysis
    Stawowczyk, Ewa
    Malinowski, Krzysztof Piotr
    Kawalec, Pawel
    Mocko, Pawel
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (05) : 759 - 786
  • [46] Traumatic Injury and Multiple Sclerosis: A Systematic Review and Meta-Analysis
    Warren, Sharon A.
    Olivo, Susan Armijo
    Contreras, Jorge Fuentes
    Turpin, Karen V. L.
    Gross, Douglas P.
    Carroll, Linda J.
    Warren, Kenneth G.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2013, 40 (02) : 168 - 176
  • [47] Multiple sclerosis and ulcerative colitis: A systematic review and meta-analysis
    Nabizadeh, Fardin
    Azizi, Ali
    Hejrati, Lina
    Mousavi, Maryam
    Mehranzadeh, Ali
    Badihian, Shervin
    Tavallaei, Mohammad Javad
    Rahmanian, Vahid
    Amiri, Bahareh Shateri
    Rafiei-Sefiddashti, Raheleh
    Hejrati, Alireza
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2023, 9 (03)
  • [48] Dental amalgam and multiple sclerosis: A systematic review and meta-analysis
    Aminzadeh, Kevin K.
    Etminan, Mahyar
    JOURNAL OF PUBLIC HEALTH DENTISTRY, 2007, 67 (01) : 64 - 66
  • [49] Antibiotic use and multiple sclerosis A systematic review and meta-analysis
    Hosseinzadeh, Ali
    Iranpour, Sohrab
    Adineh, Hossein Ali
    Aliyari, Roqayeh
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 75
  • [50] Statin Treatment in Multiple Sclerosis: A Systematic Review and Meta-Analysis
    Gorm Pihl-Jensen
    Anna Tsakiri
    Jette Lautrup Frederiksen
    CNS Drugs, 2015, 29 : 277 - 291